InvestorsHub Logo
Followers 6
Posts 186
Boards Moderated 0
Alias Born 06/23/2013

Re: 2014shelby post# 35679

Tuesday, 06/20/2017 10:25:02 PM

Tuesday, June 20, 2017 10:25:02 PM

Post# of 54978
No definitely not, see posts by Engleman on stocktwits and his communication with the company. Their prized baby is X-22 and approval from FDA will open up doors in the US and worldwide, equating to hundreds of millions in revenue. Hemp is their complementary program - finding additional windows of opportunity to commercialise their R&D efforts is certainly worthwhile (and why not), given the multifaceted uses and applications for hemp. It's another feather in their cap!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News